Nabriva TherapeuticsNBRVF
13F holders, Q4 2025 (December 31)2holders +1
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q4 2025, 2 institutions reported holding Nabriva Therapeutics PLC (NBRVF) in their 13F filings, up 1 from Q3 2025. 1 opened new positions and 0 sold out. The largest holders were Bay Harbor Wealth Management, LLC ($0) and Motiv8 Investments LLC ($0).
- Company
- Nabriva Therapeutics PLC
- CUSIP
- G63637139
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 6 shares bought, net +6 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Bay Harbor Wealth Management, LLC | 0.00% | No change | 80 | $0 |
| Motiv8 Investments LLC | 0.00% | New | 6 | $0 |
"% of holder's portfolio" is NBRVF's weight in each manager's 13F, not the share of Nabriva Therapeutics PLC the manager owns.